Email Updates

You are here

Home»Trial Summary Table

Trial Summary Table

Trial Name Phase Start Date Sponsors Countries Population Candidate(s) Status Expected Completion Date
MTN 034 / IPM 045 / REACH II Monday, January 14, 2019 NIAID (DAIDS-ES: 12066), NICHD, NIMH, NIH, IPM South Africa, Kenya, Zimbabwe, Uganda Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing October 2021
MTN 035 (DESIRE) Open Label Tuesday, April 9, 2019 NIAID (DAIDS-ES: 38459) Malawi, Peru, South Africa, Thailand, United States of America Men, Transgender men, Transgender women Ongoing July 2020
MTN 036 / IPM 047 I Monday, December 4, 2017 NIAID, NICHD, NIMH, NIH, IPM United States of America Women Dapivirine Ring Completed January 2019
MTN 037 I Sunday, June 17, 2018 NIAID (DAIDS-ES: 35122) United States of America Men, Women PC-1005 gel Ongoing April 2019
MTN 038 I Friday, December 7, 2018 NIAID (DAIDS-ES: 38460) United States of America Women TFV ring Ongoing September 2019
MTN 042/ DELIVER III Thursday, January 9, 2020 NIAID (DAIDS-ES: 38544) Malawi, South Africa, Uganda, Zimbabwe Pregnant women, Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing April 2023
MTN 043/ B-PROTECTED Open Label, III Monday, August 24, 2020 NIAID (DAIDS-ES: 38591) Malawi, South Africa, Uganda, Zimbabwe Adolescent/Children, Lactating women, Women Dapivirine Ring, TDF/FTC (Truvada) Completed November 2021
MTN-003C (VOICE Community Substudy) Other Tuesday, June 15, 2010 DAIDS;NIH;NIAID South Africa Women Completed July 2012
MTN-039 Open Label, I Wednesday, December 11, 2019 MTN United States of America Men, Women Elvitegravir (EVG) Ongoing March 2021
MTN-041/ MAMMA Other Thursday, May 31, 2018 NIAID (DAIDS-ES: 38161) Malawi, South Africa, Uganda, Zimbabwe Women Dapivirine Ring, TDF/FTC (Truvada) Ongoing November 2018

Pages